Suppr超能文献

卵巢颗粒细胞瘤:31例回顾性研究及文献复习

Granulosa Cell Tumor of the Ovary: A Retrospective Study of 31 Cases and a Review of the Literature.

作者信息

Dridi Manel, Chraiet Nesrine, Batti Rim, Ayadi Mouna, Mokrani Amina, Meddeb Khedija, Yahiaoui Yosra, Raies Henda, Mezlini Amel

机构信息

Department of Medical Oncology, Salah Azaïz Institute, Faculty of Medicine of Tunis, Tunis El Manar University, Tunis, Tunisia.

出版信息

Int J Surg Oncol. 2018 Mar 29;2018:4547892. doi: 10.1155/2018/4547892. eCollection 2018.

Abstract

BACKGROUND

Adult granulosa cell tumors (AGCTs) are the most common sex cord-stromal tumors. Unlike epithelial ovarian tumors, they occur in young women and are usually detected at an early stage. The aim of this study was to report the clinical and pathological characteristics of AGCT patients and to identify the prognostic factors.

METHODS

All cases of AGCTs, treated at Salah Azaïz Institute between 1995 and 2010, were retrospectively included. Kaplan-Meier's statistical method was used to assess the relapse-free survival and the overall survival.

RESULTS

The final cohort included 31 patients with AGCT. The mean age was 53 years (35-73 years). Patients mainly presented with abdominal mass and/or pain (61%, = 19). Mean tumor size was 20 cm. The majority of patients had a stage I disease (61%,   = 19). Two among 3 patients with stage IV disease had liver metastasis. Mitotic index was low in 45% of cases ( = 14). Surgical treatment was optimal in almost all cases (90%, = 28). The median follow-up time was 14 years (1-184 months). Ten patients relapsed (32%) with a median RFS of 8.4 years (6.8-9.9 years). Mean overall survival was 13 years (11-15 years). Stage I disease and low-to-intermediate mitotic index were associated with a better prognosis in univariate analysis (resp., = 0.05 and = 0.02) but were not independent prognostic factors.

CONCLUSION

GCTs have a long natural history with common late relapses. Hence, long active follow-up is recommended. In Tunisian patients, hepatic metastases were more frequent than occidental series. The prognosis remains good and initial staging at diagnosis is an important prognostic factor.

摘要

背景

成人颗粒细胞瘤(AGCTs)是最常见的性索间质肿瘤。与上皮性卵巢肿瘤不同,它们发生于年轻女性,通常在早期被发现。本研究的目的是报告AGCT患者的临床和病理特征,并确定预后因素。

方法

回顾性纳入1995年至2010年在萨拉赫·阿扎伊兹研究所接受治疗的所有AGCT病例。采用Kaplan-Meier统计方法评估无复发生存率和总生存率。

结果

最终队列包括31例AGCT患者。平均年龄为53岁(35 - 73岁)。患者主要表现为腹部肿块和/或疼痛(61%,n = 19)。平均肿瘤大小为20 cm。大多数患者为I期疾病(61%,n = 19)。3例IV期疾病患者中有2例发生肝转移。45%的病例有丝分裂指数低(n = 14)。几乎所有病例(90%,n = 28)手术治疗均为最佳。中位随访时间为14年(1 - 184个月)。10例患者复发(32%),中位无复发生存期为8.4年(6.8 - 9.9年)。平均总生存期为13年(11 - 15年)。在单因素分析中,I期疾病和低至中等丝分裂指数与较好的预后相关(分别为P = 0.05和P = 0.02),但不是独立的预后因素。

结论

颗粒细胞瘤有较长的自然病程,常见晚期复发。因此,建议进行长期积极随访。在突尼斯患者中,肝转移比西方系列更常见。预后仍然良好,诊断时的初始分期是一个重要的预后因素。

相似文献

8
Prognostic factors in adult granulosa cell tumor of the ovary.成人卵巢颗粒细胞瘤的预后因素
Cancer. 1997 May 15;79(10):1951-5. doi: 10.1002/(sici)1097-0142(19970515)79:10<1951::aid-cncr16>3.0.co;2-u.

引用本文的文献

1
Postmenopausal Presentation of Granulosa Cell Tumor: A Case Report.颗粒细胞瘤的绝经后表现:一例报告
Cureus. 2025 Jan 9;17(1):e77175. doi: 10.7759/cureus.77175. eCollection 2025 Jan.

本文引用的文献

1
Prognostic factors for recurrence in early stage adult granulosa cell tumor of the ovary.早期成年卵巢颗粒细胞瘤复发的预后因素
Arch Gynecol Obstet. 2016 Nov;294(5):1031-1036. doi: 10.1007/s00404-016-4135-5. Epub 2016 Jun 20.
3
[The observatory of rare malignant gynecologic tumors].[罕见妇科恶性肿瘤观察站]
Ann Pathol. 2014 Feb;34(1):70-3. doi: 10.1016/j.annpat.2014.01.007. Epub 2014 Feb 18.
4
[Granulosa cell tumors of the ovary].[卵巢颗粒细胞瘤]
Bull Cancer. 2014 Jan 1;101(1):93-101. doi: 10.1684/bdc.2013.1879.
5
Recent advances in granulosa cell tumor ovary: a review.颗粒细胞瘤卵巢的最新进展:综述
Indian J Surg Oncol. 2013 Mar;4(1):37-47. doi: 10.1007/s13193-012-0201-z. Epub 2012 Dec 7.
10
Granulosa cell tumor of the ovary: tumor review.卵巢颗粒细胞瘤:肿瘤综述
Integr Cancer Ther. 2008 Sep;7(3):204-15. doi: 10.1177/1534735408322845.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验